Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT06796075
- Status
- Recruiting
Conditions
- Cardiovascular Diseases
Eligibility Criteria
- Sex
- FEMALE
- Age
- 21 Years - 49 Years
- Healthy Volunteers
- Accepted
Interventions
- Mom♥Health — BEHAVIORAL12-week intervention involving 1) weekly phone calls to mothers regarding education and counseling related to heart healthy lifestyle, as well as strategies for stress reduction; 2) referral to clinical care for identified needs (e.g., elevated blood pressure); and 3) referral to available social resources (e.g., food pantry for identified food insecurity).
Study Details
This single-site research study will pilot-test a context-specific cardiovascular disease (CVD) risk prevention program, Mom♥Health, using two childhood centers at Family Health Centers (FHC) at NYU Langone as platforms for maternal engagement.
Key Dates
- Start date
- Jul 11, 2025
- Status verified
- Mar 2026
- Primary completion
- Sep 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: Socially Vulnerable MothersSocially vulnerable mothers of young children, whose children attend formal childcare, will receive telephone-delivered programs over 12 weeks. They will also attend a 6 weeks post-intervention follow-up assessment.
Primary Outcome Measure
Percentage of Participants who Complete Intervention Program [ Time Frame: Week 12 ]
Central Contacts
- Milla Arabadjian5166631668
- Mark Bond646-754-7217
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | - |
Find similar trials in New York, NY
By research site
Related Studies
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- Food and Microbiome Longitudinal Investigation (FAMiLI)Recruiting · NYU Langone Health · New York, New York
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama